Cepheid Sells Pathogen Detection Systems to FDA | GenomeWeb

NEW YORK, Sept. 8 (GenomeWeb News) - Cepheid said today that it has received an order for 16 of its Smart Cycler II starter systems from the FDA for general use in food safety testing.

Financial terms of the deal were not disclosed.

Sunnyvale, Calif.-based Cepheid said roughly 60 percent of state public health institutions use Smart Cycler systems for pathogen detection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.